Scientists from the University of Liverpool and their global collaborators have highlighted the most effective treatments for ...

The number of people living with neurological disorders, such as Alzheimer’s disease, epilepsy, multiple sclerosis and ...

Researchers at the Institute of Environmental Medicine, Karolinska Institutet have taken an important step toward ...

A new analysis of an overall survival study of an investigational immunotherapy platform to treat ALS found it slowed disease ...

Compared with adults aged 65 and older, those aged 18 to 64 are more affected by long COVID neurologic symptoms.

The company, co-founded by Nobel Laureate Craig Mello, aims to push molecules for Huntington’s and a form of epilepsy into Phase I trials, with additional preclinical assets targeting Parkinson’s and ...

Atalanta Therapeutics, a biotechnology company pioneering RNA interference (RNAi) for the treatment of neurological diseases, today announced the completion of a $97 million Series B financing to ...

Scientists from the University of Liverpool, and their global collaborators have highlighted the most effective treatments ...

Explore the applications of preclinical MRI in neurological diseases, focusing on functional and metabolic imaging techniques ...

The Clinic's study has already enrolled 3,600 participants, but the goal is a diverse group of 200,000. Right now, more men ...

One fateful morning, 75-year-old Ambika Devi suddenly felt the room around her spinning, reminiscent of an amusement park ...

Research explores the profound impact of climate change on neurological health, focusing on how rising temperatures, extreme ...